Acta Biomedica Atenei Parmensis

Published: 01-07-2020

ABM Suppl. 7-2020

ORIGINAL ARTICLES

Innovative therapies for malignant brain tumors: the road to a tailored cure

Alice Giotta Lucifero, Sabino Luzzi, Ilaria Brambilla, Chiara Trabatti, Mario Mosconi , Salvatore Savasta, Thomas Foiadelli

Abstract 830 | PDF Downloads 279 | DOI https://doi.org/10.23750/abm.v91i7-S.9951

Page 5-17

PDF

Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges

Sabino Luzzi, Alice Giotta Lucifero , Ilaria Brambilla, Mariasole Magistrali, Mario Mosconi, Salvatore Savasta, Thomas Foiadelli

Abstract 838 | PDF Downloads 312 | DOI https://doi.org/10.23750/abm.v91i7-S.9952

Page 18-31

PDF

Gene therapies for high-grade gliomas: from the bench to the bedside

Alice Giotta Lucifero , Sabino Luzzi, Ilaria Brambilla, Carmen Guarracino, Mario Mosconi, Thomas Foiadelli, Salvatore Savasta

Abstract 580 | PDF Downloads 265 | DOI https://doi.org/10.23750/abm.v91i7-S.9953

Page 32-50

PDF

The impact of stem cells in neuro-oncology: applications, evidence, limitations and challenges

Sabino Luzzi, Alice Giotta Lucifero , Ilaria Brambilla, Chiara Trabatti, Mario Mosconi, Salvatore Savasta, Thomas Foiadelli

Abstract 445 | PDF Downloads 177 Suppl table Downloads 27 | DOI https://doi.org/10.23750/abm.v91i7-S.9955

Page 51-60

PDF Suppl table

Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas

Alice Giotta Lucifero , Sabino Luzzi, Ilaria Brambilla, Lucia Schena, Mario Mosconi, Thomas Foiadelli, Salvatore Savasta

Abstract 480 | PDF Downloads 256 | DOI https://doi.org/10.23750/abm.v91i7-S.9956

Page 61-78

PDF

Targeting the medulloblastoma: a molecular-based approach

Sabino Luzzi, Alice Giotta Lucifero , Ilaria Brambilla, Simona Semeria Mantelli, Mario Mosconi, Thomas Foiadelli, Salvatore Savasta

Abstract 1030 | PDF Downloads 449 | DOI https://doi.org/10.23750/abm.v91i7-S.9958

Page 79-100

PDF

Advanced pharmacological therapies for neurofibromatosis type 1-related tumors

Thomas Foiadelli , Matteo Naso, Amelia Licari, Alessandro Orsini, Mariasole Magistrali, Chiara Trabatti, Sabino Luzzi, Mario Mosconi, Salvatore Savasta, Gian Luigi Marseglia

Abstract 703 | PDF Downloads 309 | DOI https://doi.org/10.23750/abm.v91i7-S.9961

Page 101-114

PDF

Editor-in-Chief
Maurizio Vanelli

Journal Information

Language: English
Frequency: 6 issues/year
ISSN: 0392-4203 | eISSN: 2531-6745
Cit. Ind. (Scopus): 3.5 (2022)
Indexed in: Medline, EMBASE, Elsevier BioBASE, Scopus, Bibliovigilance, PubMedCentral, Google Scholar

Acta Biomed Vol 94 No 5 (2023)

Make a Submission

Information

Warning

Dear Authors, Acta Biomedica is under a cyber attack.

Please reject all the non-official communications of Acta Biomedica and contact us before doing anything. Please note that Acta Biomedica does not send acceptance letters via email. Acceptance of articles is communicated only through the website. These cyber-attacks use false information, unauthorized Acta Biomedica logos, and a false signature of the Editor in Chief.

If you receive an email from stephen@agpapers.online, or from presidentntorgboard@gmail.com (with the subject line: "Acta Biomedica BOARD"), please be aware that this person is not affiliated with our Publishing House and has no role in the management of Acta Biomedica. The email is fraudulent and should be ignored.

The real link for our Journal is www.actabiomedica.it or https://www.mattioli1885journals.com/index.php/actabiomedica/index (Mattioli with one L, not double L). The site with double L is fake.

We hope to solve this fraudulent behavior as soon as possible.

Many thanks for your collaboration.

Sincerely yours.

Prof Maurizio Vanelli.
Editor in Chief of Acta Biomedica

Listed in:

Scopus coverage years: from 1974 to Present

Acta Bio Medica is indexed by: Medline, EMBASE, the Elsevier BioBASE, Scopus, Bibliovigilance, PubMedCentral, Google Scholar

Webinar series – IMMUNOLOGY

Publons Reviewer Recognition Service

Full Issue